A rare case of primary sellar melanoma: Case report
The authors report on the case of a 37-year-old woman in whom a primary sellar malignant melanoma mimicking a hemorrhagic pituitary macroadenoma was treated. This entity is exceedingly rare; only five cases are described in the literature. The patient presented with rapid deterioration of vision wit...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
May 2004
|
| In: |
Journal of neurosurgery
Year: 2004, Volume: 100, Issue: 5, Pages: 931-934 |
| ISSN: | 1933-0693 |
| DOI: | 10.3171/jns.2004.100.5.0931 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3171/jns.2004.100.5.0931 Verlag, lizenzpflichtig, Volltext: https://thejns.org/view/journals/j-neurosurg/100/5/article-p931.xml 
|
| Author Notes: | Jochen Tüttenberg, Wolfram Fink, Walter Back, Frederik Wenz, Dirk Schadendorf, and Claudius Thomé |
| Summary: | The authors report on the case of a 37-year-old woman in whom a primary sellar malignant melanoma mimicking a hemorrhagic pituitary macroadenoma was treated. This entity is exceedingly rare; only five cases are described in the literature. The patient presented with rapid deterioration of vision within a 2-week period. After an ophthalmological diagnosis of chiasmal syndrome was made, magnetic resonance (MR) imaging of the head revealed an intra- and suprasellar mass that was elevating and compressing the optic chiasm. Because of the signal heterogeneity of the lesion a hemorrhagic pituitary macroadenoma was assumed; the lesion was transsphenoidally resected. Histological examination of the specimen showed a malignant melanocytic tumor with immunopositivity for S100 protein and HMB-45. Despite extensive staging no other primary melanotic tumor was found. Thus, a primary sellar melanoma was diagnosed. Postoperative MR images demonstrated no residual tumor. For adjuvant therapy the region around the sella turcica received 40.4 Gy stereotactically guided radiation. A 24-month follow-up examination revealed no tumor recurrence.</p><p>This represents the sixth case of such a lesion reported in the literature, the third case evaluated using MR imaging, and the first case with a progression-free survival of 24 months. Thus, the authors advocate that management of primary sellar melanoma should include gross-total removal and postoperative stereotactic radiotherapy. |
|---|---|
| Item Description: | Gesehen am 25.11.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1933-0693 |
| DOI: | 10.3171/jns.2004.100.5.0931 |